The finely targeted specificity of Sepranolone means that it is confined to a very specific part of the GABA-A receptor, with minimal effect on any other CNS mechanism—meaning little or no side effects as a treatment:
- Fine-tuned receptor activity without overstimulation
- High selectivity
- Minimal off-target effect